TherapeuticsMD, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from TherapeuticsMD, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 96%
Sales fell 96% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-96% / -58%In 3 years sales changed by -96% while total assets changed by -58%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
2.5×Debt due within a year is covered 2.5 times by its yearly operating cash.
Higher than 75% of Healthcare companies in United States.
Cash Cushion Ratio
+6%Cash, after subtracting all debt, equals 6% of its market value (net cash).
Lower than 55% of Healthcare companies in United States.
Tangible Assets Ratio
90%Of every $100 the company owns, $90 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 62% of Healthcare companies in United States.
Tangible Net Worth Ratio
86%Of every $100 of net worth, $86 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 67% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
TherapeuticsMD, Inc. made a loss over the last year. TherapeuticsMD, Inc. owes $0.28 for every $1 it owns. TherapeuticsMD, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTherapeuticsMD, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.79The share price is 0.79 times TherapeuticsMD, Inc.'s book value per share, lower than 84% of Healthcare companies in United States.
Market cap
$21 MThe total market value of all of TherapeuticsMD, Inc.'s shares at today's price (share price × number of shares), smaller than 82% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$27 MWhat TherapeuticsMD, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
$2.33Net worth divided by the number of shares. The share price of $1.85 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
-1.1%TherapeuticsMD, Inc. lost 1.1% of its shareholders' money over the last year, higher than 75% of Healthcare companies in United States.
Owes vs Owns
0.28×TherapeuticsMD, Inc. owes $0.28 for every $1 it owns (low), lower than 62% of Healthcare companies in United States.
Dividend yield
NoneTherapeuticsMD, Inc. does not currently pay a dividend.
Revenue growth
+72%Revenue rose 72% in the year to Dec 2025, and shrank 65% a year on average over 3 years.
Profit growth
LossTherapeuticsMD, Inc. made a loss in each of the last two years.
Profit margin
-18.8%TherapeuticsMD, Inc. lost $19 for every $100 of revenue.
Cash vs debt
Net cashTherapeuticsMD, Inc. held $1 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For TherapeuticsMD, Inc.: $21 M ÷ $27 M (31 Mar 2026) = 0.8.
What is TherapeuticsMD, Inc.'s return on equity?
TherapeuticsMD, Inc. lost 1.1% of its shareholders' money over the last year, higher than 75% of Healthcare companies in United States.
How much does TherapeuticsMD, Inc. owe compared with what it owns?
TherapeuticsMD, Inc. owes $0.28 for every $1 it owns (low), lower than 62% of Healthcare companies in United States.
Does TherapeuticsMD, Inc. pay a dividend?
No. TherapeuticsMD, Inc. does not currently pay a dividend.
Is TherapeuticsMD, Inc.'s revenue growing?
Revenue rose 72% in the year to Dec 2025, and shrank 65% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.